Ghasem Ahangari | Neuroscience | Excellence in Research

Published on by Popular Engineer

Prof. Ghasem Ahangari | Neuroscience | Excellence in Research

National Institute of Genetic Engineering and Biotechnology | Iran

Professor Ghasem Ahangari is a senior academic and research leader in medical biotechnology, molecular immunology, and neuroimmunogenetics, with more than three decades of sustained contributions to translational biomedical science.  He holds academic training in medical technology, hematology, and molecular clinical immunology, with advanced research experience in internationally recognized institutions, including the Karolinska Institute. His professional career includes long-term faculty appointments, departmental leadership, institute directorships, and coordination of national and international scientific programs. His research interests center on complex disorders such as cancer, autoimmune diseases, neuroimmune and psychosomatic conditions, inflammation, neurotransmitter receptor signaling, and molecular diagnostics, with increasing integration of artificial intelligence in medical research. Professor Ahangari has authored numerous high-impact journal articles, books, and patents, supervised graduate researchers, and organized major scientific workshops and symposia. He is a recipient of multiple academic and research awards from national and international scientific bodies. Overall, his career reflects a strong commitment to interdisciplinary research, academic leadership, and advancing precision medicine through molecular and systems-level approaches.

Citation Metrics (Google Scholar)

2000
1600
600
200
0

Citations
1998

Documents
29
h-index
19

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications

Milad Shirvaliloo | Genetics and Genomics | Best Researcher Award

Published on by Popular Engineer

Dr. Milad Shirvaliloo | Genetics and Genomics | Best Researcher Award

Iran University of Medical Sciences | Iran

Milad Shirvaliloo holds an MD and an MBA in Health Sciences and is an aspiring physician-researcher with over six years of investigative experience in epigenetics, cancer biology and pulmonary medicine. He has published more than 40 peer-reviewed articles and a book chapter, and serves on the Editorial Board of Epigenomics and as reviewer for 60+ Web of Science-indexed journals. His academic journey includes medical education at Tabriz University of Medical Sciences and postgraduate research at Iran University of Medical Sciences  focusing on nanoparticle-based therapeutic interventions and histone acetylation in cancer. His work spans diagnostics (e.g., nano-biosensor assays for SARS-CoV-2), lung epithelium development (epigenetic cues in human lung organoids) and cancer nano-theranostics (targeted magnetochemotherapy and histone modification mapping). According to h-index is 16 and he has amassed over 819 citations to date. His main research interests include histone modifications, chromatin accessibility, nanoparticle-mediated drug delivery and epigenetic biomarkers in respiratory and oncologic diseases. He brings strong skills in scientific communication, evidence synthesis, statistical & bioinformatics analysis and R programming. In conclusion, Milad’s interdisciplinary expertise positions him at the interface of molecular epigenetics and translational nanomedicine with the aim to advance precision diagnostics and therapies.

Profiles : Scopus | Google Scholar 

Featured Publications

Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & Youshanlouei, H. R., et al. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & Pilehvar-Soltanahmadi, Y., et al. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & Sheervalilou, R., et al. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & Fathi-Karkan, S., et al. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.

Marwa Hassan | Molecular Biology | Best Researcher Award

Published on by Popular Engineer

Assist. Prof. Dr. Marwa Hassan | Molecular Biology | Best Researcher Award

Theodor Bilharz Research Institute | Egypt

Marwa Hassan is an immunologist with substantive contributions in stem cell biology, molecular immunology, and translational research. She also holds a Postgraduate Diploma in Healthcare & Hospital Management (American University in Cairo, 2020). Over her career she has held roles from resident researcher to acting head of department at the Immunology Division of TBRI, and has organized and led numerous specialized training courses (e.g. stem cell culture, molecular immunology, ELISA). Her research interests include non-coding RNAs, stem cell differentiation, immune regulation in liver disease, and biomarker development. She has published in peer-reviewed journals (e.g. on circulating liver cancer stem cells) and contributed to capacity building via workshops and academic leadership. Her awards and recognitions reflect her dual strengths in research and academic service. In sum, Dr. Hassan combines rigorous scientific inquiry with institutional leadership, advancing immunology and regenerative medicine in Egypt and beyond.

Profile : Orcid

Featured Publications

Ahmed, M. H. M., & Abdel Hamid, H. M. (2022). Circulating liver cancer stem cells: Clinical implications and future perspectives. World Journal of Gastroenterology, 28(1), 39–52

Ahmed, M. H. M., El Refai, S., & El-Shenawy, R. (2021). MicroRNA-based biomarkers in hepatitis C virus-induced hepatocellular carcinoma. Egyptian Journal of Immunology, 28(2), 75–90.

Ahmed, M. H. M., Hussein, M., & El Sayed, A. (2020). Impact of mesenchymal stem cell passaging on proliferation and differentiation potential. Theodor Bilharz Medical Journal, 18(4), 201–210.

Ahmed, M. H. M., Ibrahim, N., & Khalifa, M. (2019). Role of regulatory T-cells in autoimmune liver diseases: An immunopathological study. Journal of Clinical and Experimental Hepatology, 9(3), 355–362.

Ahmed, M. H. M., & El Demerdash, R. (2017). Gene expression profiling of umbilical cord blood-derived mesenchymal stem cells under oxidative stress. Stem Cell Research & Therapy, 8(1), 112.

Yan Ding | Biology and Life Sciences | Excellence in Research

Published on by Popular Engineer

Prof. Yan Ding | Biology and Life Sciences | Excellence in Research

China Medical University | China

Dr. Yan Ding is a biomedical researcher with a doctorate from China Medical University, Shenyang. Her academic training includes a Bachelor’s degree from Shenyang Pharmaceutical University, a Master’s and PhD from China Medical University. Since 2013, she has progressed through roles in experimental research—assistant experimentalist, experimentalist, and since 2022, senior experimentalist—at the Institute of Metabolic Disease Research & Drug Development and the College of Basic Medical Science. Her research focuses on molecular and cellular mechanisms underlying lung injury, inflammation, epithelial sodium transport, miRNA regulation, pulmonary fibrosis and herbal / natural compounds’ effects. She has published numerous first-author papers addressing roles of miRNAs (e.g. miR-130a-3p, miR-199a-3p, miR-21), luteolin’s therapeutic potential, regulation of epithelial sodium channel (ENaC), anti-oxidant and anti-inflammatory pathways. she has an h-index of 6 with 143 citations overall. Throughout her career, she has also contributed to studies of lung fluid clearance, regulatory mechanisms during viral infections, and herbal monomers in edematous disorders. Awards include recognition for excellence in experimental work (institutional). In conclusion, Dr. Ding is an emerging researcher building a solid track record in pulmonary molecular biology, with demonstrated expertise in miRNAs, ion channel regulation, and translational potential in lung disease therapy.

Profile : Google scholar

Featured Publications

“Factors influencing the provision of public health services by village doctors in   Hubei and Jiangxi provinces,
China”

“Practical actions for fostering cross-disciplinary global health research: lessons from a narrative literature         review”

“Healthcare seeking behaviour among Chinese elderly”

“A cost-effectiveness analysis of three components of a syndromic surveillance system for the early warning of   epidemics in rural China”

“Qualitative study exploring lessons from Liberia and the UK for building a people-centred resilient health system response to COVID-19”